{
    "title": "Profits panacea for GlaxoSmith-Kline as swine flu vaccine orders soar",
    "url": "https://www.dailymail.co.uk/money/article-1218600/Profits-panacea-GlaxoSmith-Kline-swine-flu-vaccine-orders-soar.html",
    "date": "2009-10-06",
    "keywords": [
        "vaccine",
        "share",
        "flu",
        "swine",
        "commission",
        "glaxosmithkline",
        "government",
        "group",
        "japan",
        "glaxo",
        "quarter",
        "wave",
        "yesterday",
        "deal",
        "court",
        "spain",
        "trade",
        "karl",
        "west",
        "gmt",
        "view",
        "demand",
        "number",
        "company",
        "worth",
        "world",
        "china",
        "update",
        "august",
        "line",
        "profit",
        "windfall",
        "cashing",
        "giant",
        "analyst",
        "citigroup",
        "medication",
        "week",
        "mass",
        "immunisation",
        "infection",
        "winter",
        "novartis",
        "contract",
        "population",
        "h1n1",
        "march",
        "california",
        "mexico",
        "health",
        "regulator",
        "ready",
        "use",
        "way",
        "article",
        "boost",
        "competition",
        "veto",
        "drug",
        "advantage",
        "companys",
        "request",
        "attempt",
        "markup",
        "justice",
        "evidence",
        "ruling",
        "position",
        "eus",
        "prescription",
        "market"
    ],
    "category": [
        "money"
    ]
}